The Senate Finance Committee wants to create a new program to incentivize better practices. Critics say there’s an easier way: end kickbacks between suppliers and bulk purchasers. Read this story
The Senate Finance Committee wants to create a new program to incentivize better practices. Critics say there’s an easier way: end kickbacks between suppliers and bulk purchasers. Read this story
More from The American Prospect | Health & Social Policy Big Pharma prescription drugs hospitals GPOs PBMs corporate power monopoly Medicare Medicaid Federal Trade Commission Congress David Dayen